speb/financial-data huggingface dataset:
ACMESOLAR.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 270380000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 260000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 260000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3814110000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3814110000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 162523820000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 162523820000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Gross Profit: 13540560000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 2750000000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 2750000000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Interest Expense: 7592070000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 2055460000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 7592070000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2055460000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Interest Income: 1335890000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 1335890000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -9634340000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 1530380000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Inventory: 39270000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 39270000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 149332810000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 149332810000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -39761300000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 14020000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 14020000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 3363520000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 3363520000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 22932880000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 66528150000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 2009850000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2009850000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 5048310000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5048310000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 98571700000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 98571700000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 103620010000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 103620010000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 65239420000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -45139340000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 45980000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 45980000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 139402240000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 139402240000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -12880000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -12880000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Minority Interests: 12870000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 12870000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 22932880000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Net Debt: 91709550000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 91709550000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 390000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income: 2521080000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income: 1233620000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2521080000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1233620000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 2508210000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1220750000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2521080000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1233620000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2521080000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1233620000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 3380360000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 2508210000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1220750000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Interest Income: -7592070000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -2055460000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -7964640000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 21388810000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 20100080000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -7592070000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2055460000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -50000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Net PPE: 136813960000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 136813960000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -32620660000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 1288730000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 45105540000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 45105540000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 143790000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 143790000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 17144120000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 17144120000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 2634510000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2634510000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4884470000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4884470000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 54590000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 54590000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 968510000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 968510000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 14055400000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4881150000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Normalized Income: 2676780217.25
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1337011541.92
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 15430190000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Operating Income: 9481170000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Operating Income: 3335270000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Operating Revenue: 14051310000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4868870000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 605087781.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 605087781.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 797610000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 797610000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 95940000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 95940000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 240860000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 240860000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 260000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 260000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 6149600000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 346330000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 346330000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 17144120000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 17144120000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1701100000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 523680000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1047560000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 338680000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Payable: 2537280000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 2537280000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Properties: 7402910000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 7402910000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1491090000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1491090000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 8903260000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8903260000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Other Special Charges: 209840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 140820000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Payables: 4784540000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Payables: 4784540000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 38380000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 38380000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 2279120000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2279120000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Pretax Income: 3380360000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1662670000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -9512510000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -32659930000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 39270000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 39270000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 510750000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2873130000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1022200000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 38410000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 38410000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -45139340000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 7739600000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 7739600000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 5486850000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 5486850000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1547870000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 39270000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 270380000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Share Issued: 605087781.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 605087781.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 1288730000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Special Income Charges: -209840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -140820000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 240860000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 45105800000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 45105800000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 45105540000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 45105540000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -54139782.75
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -37428458.08
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Tax Provision: 872150000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 441920000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 35040000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 35040000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1324190000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Assets: 184037390000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 184037390000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 143677500000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 143677500000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Debt: 109757290000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 109757290000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 45092920000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 45092920000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Total Expenses: 4570140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1533600000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 138944470000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 138944470000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 146219930000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 146219930000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 125749170000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 125749170000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 84250000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 1460000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1460000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -209840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -140820000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -209840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -140820000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Working Capital: 24622160000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 24622160000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1607230000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 5109840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 605694444.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 2.16
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1075510000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1075510000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 611355140.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.14
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1308300000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — EBIT: 4073560000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — EBITDA: 5149070000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2329630000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2329630000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -60000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income: 1308300000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1308300000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1308240000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1308300000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1308300000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1308240000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2329630000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2329630000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 5308180000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1427659186.66
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3502610000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 5109840000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 730060000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 373680000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 1743930000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1075510000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: -159110000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -39750813.34
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 435690000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1607230000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -159110000.00
ACMESOLAR.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -159110000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1723250000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4966220000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 604861702.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.88
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1201810000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1201810000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 608096257.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.87
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — EBIT: 4443160000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — EBITDA: 5644970000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 2880260000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2880260000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 50000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1137090000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1137090000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2880260000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2880260000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 5644970000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1137140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3242970000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4966220000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1200190000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 364850000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1562900000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1201810000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 425810000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1723250000.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ACMESOLAR.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — +Operating Expense: 7095250000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1917250000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — +Total Revenue: 20229590000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 5477680000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 152700000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 152700000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 3329470000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3329470000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 95760000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 95760000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 5911330000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 5911330000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 605479369.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 605726087.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Basic EPS: 8.24
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.30
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 12842730000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -53212040000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 9082450000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 9082450000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1210780000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1210780000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 22309430000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 22309430000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 63031840000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 63031840000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -242100000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -134460000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -3045600000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -1097510000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Payable: -2100490000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 478720000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -5842600000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 9466700000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1210780000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1210780000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -242100000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 50614820000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 50614820000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 600000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 43576600000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 43576600000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Assets: 69857380000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 69857380000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 633000000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 633000000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Debt: 22481730000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 22481730000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 23114730000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 23114730000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 32201590000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 32201590000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 17190000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 17190000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Depreciation: 4679020000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4679020000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4679020000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1227930000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4679020000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1227930000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 611415441.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 613731278.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Diluted EPS: 8.16
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.27
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 4989150000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1393170000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — EBIT: 17998120000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — EBIT: 5274400000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — EBITDA: 22677140000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — EBITDA: 6502330000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — End Cash Position: 22309430000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 70154590000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -40726130000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -518810000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 39280000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 250000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 250000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 200892680000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 200892680000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Interest Expense: 11229880000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 3374780000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 11229880000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3374780000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -14972930000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 2665940000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Inventory: 173730000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 173730000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 240495310000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 240495310000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -73173800000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 0.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 0.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 5911330000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5911330000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 600000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 125940960000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 8449450000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 8449450000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 167398760000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 167398760000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 175848210000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 175848210000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 121187710000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -38922460000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 144580000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 144580000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Minority Interest: -13140000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: -13140000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Minority Interests: 10300000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 10110000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -50000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 600000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Net Debt: 167571060000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 167571060000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 5930000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income: 4989150000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income: 1393170000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 4989150000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1393170000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 4978850000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1383060000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4989150000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1393170000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4989150000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1393170000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 6768240000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 4978850000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1383060000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Interest Income: -11229880000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -3374780000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -24522420000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 87018500000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 82265250000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -11229880000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3374780000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 10000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Net PPE: 200892680000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 200892680000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -53191630000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 4753250000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 50614570000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 50614570000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 3949720000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 3949720000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4388860000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 4388860000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 22650370000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6358940000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Normalized Income: 4969457463.31
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1288771765.93
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 12485910000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Operating Income: 13134340000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3560430000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Operating Revenue: 20229590000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 5477680000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 605388914.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 605388914.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 3226580000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3226580000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1637530000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1637530000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 49404040000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 49404040000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 7937800000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 4529140000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 4529140000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 19735020000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 19735020000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 4837010000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1570580000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1800740000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 541330000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Properties: 157316080000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 157316080000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 40722410000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 40722410000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Other Special Charges: -26770000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -143390000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Payables: 629790000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Payables: 629790000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Pretax Income: 6768240000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1899620000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -50000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -24708300000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -53212040000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4679020000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1227930000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -38922460000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 185880000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 20410000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Share Issued: 605971804.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 605971804.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 4753250000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Special Income Charges: 26770000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 143390000.00
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 91450000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 50614820000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 50614820000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 50614570000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 50614570000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 7077463.31
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 38991765.93
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Tax Provision: 1789390000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 516560000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
ACMESOLAR.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -821680000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Assets: 285403090000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 285403090000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 218013580000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 218013580000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Debt: 198962940000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 198962940000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 50601680000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 50601680000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Total Expenses: 7095250000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1917250000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 234801410000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 234801410000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 215545710000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 215545710000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 202599820000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 202599820000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 477090000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 477090000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 26770000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 143390000.00
ACMESOLAR.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 26770000.00
ACMESOLAR.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 143390000.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 582890.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 582890.00
ACMESOLAR.NS balance_sheet (annual, 2026-03-31) — Working Capital: 37655790000.00
ACMESOLAR.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 37655790000.00
ACMR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
ACMR cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
ACMR cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 0.00
ACMR cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
ACMR cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -1568000.00
ACMR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
ACMR cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 545512000.00
ACMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 9065000.00
ACMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 7763000.00
ACMR balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 1302000.00
ACMR balance_sheet (annual, 2021-12-31) — Other Investments: 12694000.00
ACMR cash_flow (annual, 2021-12-31) — Purchase Of Business: -1568000.00
ACMR cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
ACMR balance_sheet (annual, 2021-12-31) — Taxes Receivable: 1082000.00
ACMR income_statement (annual, 2022-12-31) — +Operating Expense: 124580000.00
ACMR income_statement (annual, 2022-12-31) — +Total Revenue: 388832000.00
ACMR balance_sheet (annual, 2022-12-31) — Accounts Payable: 101735000.00
ACMR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 182936000.00
ACMR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -10047000.00
ACMR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 604089000.00
ACMR balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ACMR balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 101956000.00
ACMR income_statement (annual, 2022-12-31) — Basic Average Shares: 59235975.00